Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Revenue

Takeda Pharmaceutical had revenue of 1.19T JPY in the quarter ending September 30, 2026, with 6.68% growth. This brings the company's total for the last twelve months to 4.69T, up 6.25% year-over-year. In the fiscal year ending March 31, 2026, Takeda Pharmaceutical had annual revenue of 4.51T, down -1.66%.

• Revenue (ttm): 4.69T JPY
• Revenue Growth: +6.25%
• P/S Ratio: 2.22
• Revenue / Employee: 99,793,744 JPY
• Employees: 47,029
• Market Cap: 66.42B USD

Revenue Chart

Chart

Chart

* This company reports financials in JPY.

Revenue by Segment

By Segment

Chart

• GI 1.41T 31.2%
• PDT 1.06T 23.5%
• Rare Diseases 762.70B 16.9%
• Oncology 580.13B 12.9%
• Neuroscience 414.34B 9.2%
• Other Product 223.96B 5.0%
• Vaccines 59.61B 1.3%

By Geography

Chart

• United States 2.16T 48.0%
• Europe and Canada 1.15T 25.4%
• Japan 433.11B 9.6%
• Latin America 254.13B 5.6%
• China 195.14B 4.3%
• Other Geographic 133.89B 3.0%
• Asia (ex-Japan & China) 98.67B 2.2%
• Russia / CIS 79.72B 1.8%

Fiscal year ended Mar 31, 2026 See the full Takeda Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.51T	-75.83B	-1.66%
Mar 31, 2025	4.58T	317.79B	7.45%
Mar 31, 2024	4.26T	236.26B	5.87%
Mar 31, 2023	4.03T	458.50B	12.85%
Mar 31, 2022	3.57T	371.19B	11.61%
Mar 31, 2021	3.20T	-93.38B	-2.84%
Mar 31, 2020	3.29T	1.19T	56.93%
Mar 31, 2019	2.10T	326.69B	18.45%
Mar 31, 2018	1.77T	38.48B	2.22%
Mar 31, 2017	1.73T	-75.33B	-4.17%
Mar 31, 2016	1.81T	29.55B	1.66%
Mar 31, 2015	1.78T	86.14B	5.09%
Mar 31, 2014	1.69T	134.42B	8.63%
Mar 31, 2013	1.56T	48.34B	3.20%
Mar 31, 2012	1.51T	89.55B	6.31%
Mar 31, 2011	1.42T	-46.58B	-3.18%
Mar 31, 2010	1.47T	-72.37B	-4.70%
Mar 31, 2009	1.54T	163.53B	11.90%
Mar 31, 2008	1.37T	69.64B	5.34%
Mar 31, 2007	1.31T	92.96B	7.67%
Mar 31, 2006	1.21T	89.25B	7.95%
Mar 31, 2005	1.12T	-	-

Data Source: Fiscal.ai Last updated: Oct 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error